stockrowIDEAYA Biosciences, Inc.
IDYA Healthcare Biotechnology
IDEAYA Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $218.7 million, up 3,024.4% from fiscal 2024.
- Revenue
- −95.1%
- EPS
- −190.5%
- Free cash flow
- −165.9%
Quarter to September 2026, against a year earlier
Follow IDYA
Alert me
IDEAYA Biosciences, Inc. (IDYA) Operating margin
IDEAYA Biosciences, Inc.'s operating margin over the twelve months to 30 September 2026 was −1,267.4%, down 1194.5 percentage points from fiscal 2025 (−72.8%). Over the past ten years it has ranged from −4,671.1% (fiscal 2024) to 0.00% (fiscal 2019); the current reading is higher than 67% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −72.8% | 4,598.23 |
| FY2024 | −4,671.1% | (4,096.22) |
| FY2023 | −574.9% | (452.13) |
| FY2022 | −122.7% | 57.19 |
| FY2021 | −179.9% | 0.99 |
| FY2020 | −180.9% | (180.90) |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −1,343.8% | 36.93 |
| Jun 2026 | −1,380.7% | 273.90 |
| Mar 2026 | −1,654.6% | (785.10) |
| Dec 2025 | −869.5% | (921.71) |
| 29 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ELVN Enliven Therapeutics, Inc. compare | 0.00% |
| DYN Dyne Therapeutics, Inc. compare | 0.00% |
| CELC Celcuity, Inc. compare | 0.00% |
| TARS Tarsus Pharmaceuticals, Inc. compare | −102.0% |
| BEAM Beam Therapeutics Inc. compare | −267.7% |
| IDYA IDEAYA Biosciences, Inc. | −1,267.4% |
| VRDN Viridian Therapeutics, Inc. compare | −1,781.4% |
| DNLI Denali Therapeutics Inc. compare | −2,349.0% |
| TLX Telix Pharmaceuticals Limited compare | — |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on IDYA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement